ROWLAND LLOYD A

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$92,970.00
Insider Sells Quantity
6
Insider Sells Sum
$40,888.42

Insider Activity of ROWLAND LLOYD A

According to the SEC Form 4 filings, ROWLAND LLOYD A, being in a position of

  1. General Counsel at CytomX Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 13526 shares for $21,754,
    over all time since 2019-03-04, has bought 9000 shares for $92,970, and sold 26651 share for $40,888.

The largest purchase of all time was on 2019-03-04 and amounted to 9000 shares of CytomX Therapeutics, Inc. for $92,970.

The largest sale of all time was on 2024-03-19 and amounted to 5268 shares of CytomX Therapeutics, Inc. for $10,986.

Biography of ROWLAND LLOYD A

No biography is available at this moment.

2024-08-20SaleCytomX Therapeutics, Inc.
CTMX
General Counsel
4,181
0.0053%
$1.23$5,139-5.65%
2024-03-19SaleCytomX Therapeutics, Inc.
CTMX
General Counsel
5,268
0.0074%
$2.09$10,986-34.86%
2023-12-20SaleCytomX Therapeutics, Inc.
CTMX
General Counsel
4,077
0.0063%
$1.38$5,629+15.58%
2023-09-22SaleCytomX Therapeutics, Inc.
CTMX
General Counsel
5,486
0.0083%
$1.30$7,135+14.06%
2023-03-16SaleCytomX Therapeutics, Inc.
CTMX
General Counsel
2,037
0.0031%
$1.98$4,031-20.62%
2022-07-19SaleCytomX Therapeutics, Inc.
CTMX
General Counsel
5,602
0.0081%
$1.42$7,968+10%
2019-03-04PurchaseCytomX Therapeutics, Inc.
CTMX
General Counsel
9,000
0.0195%
$10.33$92,970-14.19%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.